Fresenius SE

Welcome to Fresenius Investor Relations!

Here, you will find a wide range of facts and figures about Fresenius SE, its shares, current business development and corporate governance.

If you have any questions, just mail us at ir-fre@fresenius.com. We will be pleased to help.

Current News

03.06.2009Fresenius announces Senior Notes Offering
03.06.2009Fresenius successfully raises € 138 million via a tap to its 2006 Senior Notes
30.04.2009Q1 2009: Successful start into 2009
(for additional tables please see pdf-file)
PDF Text as PDF-file
23.04.2009Fresenius Biotech receives approval for Removab® by European Commission - First Drug worldwide for Treatment of Malignant Ascites
PDF Text as PDF-file
05.03.2009Fresenius SE joins the DAX 30
PDF Text as PDF-file
Home  >  Investor Relations